Literature DB >> 16265343

Reversible cardiomyopathy caused by administration of interferon alpha.

Aarif Y Khakoo1, Marc K Halushka, J Eduardo Rame, E Rene Rodriguez, Edward K Kasper, Daniel P Judge.   

Abstract

BACKGROUND: A 56-year-old man with normal cardiac function received treatment with interferon alpha-2b for malignant melanoma. Eight months after the initiation of therapy he developed fatigue and dyspnea on exertion. Two months later, he was admitted to hospital with ORTHOPNEA, worsening dyspnea and cough. Physical examination findings were consistent with congestive heart failure. Laboratory studies were notable for hypothyroidism. Echocardiography revealed severe, global left-ventricular dysfunction. INVESTIGATIONS: Echocardiogram, electrocardiogram, serum chemistries, coronary angiography, right-heart and left-heart catheterization and endomyocardial biopsy. DIAGNOSIS: Interferon alpha-2b-induced cardiomyopathy. MANAGEMENT: Intravenous dobutamine and dopamine for cardiogenic shock and discontinuation of interferon alpha-2b.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16265343     DOI: 10.1038/ncpcardio0069

Source DB:  PubMed          Journal:  Nat Clin Pract Cardiovasc Med        ISSN: 1743-4297


  8 in total

1.  Pericardial effusion and tamponade following interferon alpha treatment for locally advanced melanoma.

Authors:  Jennifer Rauw; Shaheeda Ahmed; Teresa Petrella
Journal:  Med Oncol       Date:  2011-04-17       Impact factor: 3.064

2.  Acute myocardial infarction and cardiogenic shock: prognostic impact of cytokines: INF-γ, TNF-α, MIP-1β, G-CSF, and MCP-1β.

Authors:  R Prondzinsky; S Unverzagt; H Lemm; N Wegener; K Heinroth; U Buerke; M Fiedler; J Thiery; J Haerting; K Werdan; M Buerke
Journal:  Med Klin Intensivmed Notfmed       Date:  2012-07-20       Impact factor: 0.840

Review 3.  Anti-vascular endothelial growth factor therapies and cardiovascular toxicity: what are the important clinical markers to target?

Authors:  Christos Vaklavas; Daniel Lenihan; Razelle Kurzrock; Apostolia Maria Tsimberidou
Journal:  Oncologist       Date:  2010-02-05

Review 4.  Cardiotoxicity of Systemic Melanoma Treatments.

Authors:  Neha Mukunda; Srilakshmi Vallabhaneni; Benedicte Lefebvre; Michael G Fradley
Journal:  Curr Treat Options Oncol       Date:  2022-02-22

5.  Intravenous Injection of Coronavirus Disease 2019 (COVID-19) mRNA Vaccine Can Induce Acute Myopericarditis in Mouse Model.

Authors:  Can Li; Yanxia Chen; Yan Zhao; David Christopher Lung; Zhanhong Ye; Wenchen Song; Fei-Fei Liu; Jian-Piao Cai; Wan-Man Wong; Cyril Chik-Yan Yip; Jasper Fuk-Woo Chan; Kelvin Kai-Wang To; Siddharth Sridhar; Ivan Fan-Ngai Hung; Hin Chu; Kin-Hang Kok; Dong-Yan Jin; Anna Jinxia Zhang; Kwok-Yung Yuen
Journal:  Clin Infect Dis       Date:  2022-06-10       Impact factor: 20.999

6.  Metastatic melanoma presenting as polymorphic ventricular tachycardia.

Authors:  Jyoti Sharma; Jonathan Matthew Brunson; Nada Memon; Aarif Y Khakoo
Journal:  Tex Heart Inst J       Date:  2012

Review 7.  The cGAS-STING signaling in cardiovascular and metabolic diseases: Future novel target option for pharmacotherapy.

Authors:  Patrick Kwabena Oduro; Xianxian Zheng; Jinna Wei; Yanze Yang; Yuefei Wang; Han Zhang; Erwei Liu; Xiumei Gao; Mei Du; Qilong Wang
Journal:  Acta Pharm Sin B       Date:  2021-05-20       Impact factor: 11.413

8.  Elevated type I interferon responses potentiate metabolic dysfunction, inflammation, and accelerated aging in mtDNA mutator mice.

Authors:  Yuanjiu Lei; Camila Guerra Martinez; Sylvia Torres-Odio; Samantha L Bell; Christine E Birdwell; Joshua D Bryant; Carl W Tong; Robert O Watson; Laura Ciaccia West; A Phillip West
Journal:  Sci Adv       Date:  2021-05-26       Impact factor: 14.136

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.